这是一种治疗过度活跃膀胱的新方法，女性需要尿失禁。

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL

Byulleten Sibirskoy Meditsiny Pub Date : 2012-01-01 DOI:10.20538/1682-0363-2012-2-115-121

А. И. Неймарк, М. В. Раздорская, Игорь Владимирович Снегирёв

{"title":"这是一种治疗过度活跃膀胱的新方法，女性需要尿失禁。","authors":"А. И. Неймарк, М. В. Раздорская, Игорь Владимирович Снегирёв","doi":"10.20538/1682-0363-2012-2-115-121","DOIUrl":null,"url":null,"abstract":"The combination of α 1 adrenoceptor blocking agent and phosphodiesterase inhibitor of 5 th type is efficient in treatment of women with hyperactive bladder and urge urinary incontinence, which was proved by the studies of urodynamic and microcirculation of mucous coat of bladder.","PeriodicalId":43691,"journal":{"name":"Byulleten Sibirskoy Meditsiny","volume":"11 1","pages":"115-121"},"PeriodicalIF":0.2000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Новое в лечении гиперактивного мочевого пузыря с императивным недержанием мочи у женщин\",\"authors\":\"А. И. Неймарк, М. В. Раздорская, Игорь Владимирович Снегирёв\",\"doi\":\"10.20538/1682-0363-2012-2-115-121\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The combination of α 1 adrenoceptor blocking agent and phosphodiesterase inhibitor of 5 th type is efficient in treatment of women with hyperactive bladder and urge urinary incontinence, which was proved by the studies of urodynamic and microcirculation of mucous coat of bladder.\",\"PeriodicalId\":43691,\"journal\":{\"name\":\"Byulleten Sibirskoy Meditsiny\",\"volume\":\"11 1\",\"pages\":\"115-121\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Byulleten Sibirskoy Meditsiny\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20538/1682-0363-2012-2-115-121\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Byulleten Sibirskoy Meditsiny","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20538/1682-0363-2012-2-115-121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

α 1肾上腺素能受体阻滞剂联合第5型磷酸二酯酶抑制剂治疗女性膀胱多动性急迫性尿失禁有效，经尿动力学和膀胱粘膜微循环研究证实。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Новое в лечении гиперактивного мочевого пузыря с императивным недержанием мочи у женщин

The combination of α 1 adrenoceptor blocking agent and phosphodiesterase inhibitor of 5 th type is efficient in treatment of women with hyperactive bladder and urge urinary incontinence, which was proved by the studies of urodynamic and microcirculation of mucous coat of bladder.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊